PHBI vs AAPL: Which Stock is Better?
Side-by-side comparison of Pharmagreen Biotech Inc. and Apple Inc in 2026
PHBI
Pharmagreen Biotech Inc.
$0.00
AAPL
Apple Inc
$269.84
Key Metrics Comparison
| Metric | PHBI | AAPL | Winner |
|---|---|---|---|
| Market Cap | $0.83M | N/A | PHBI |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | -0.3% | 0.2% | AAPL |
| Gross Margin | 44.9% | 47.3% | AAPL |
Analyze PHBI
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHBI or AAPL a better investment?
Comparing PHBI and AAPL: Pharmagreen Biotech Inc. has a market cap of $0.83M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHBI and AAPL?
PHBI (Pharmagreen Biotech Inc.) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHBI or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHBI or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.3% for PHBI.
Which company is more profitable: PHBI or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 44.9% for PHBI.
Which is the larger company: PHBI or AAPL?
Pharmagreen Biotech Inc. (PHBI) is larger with a market cap of $0.83M compared to N/A for AAPL.
Should I buy PHBI or AAPL in 2026?
Both PHBI and AAPL have investment merit. PHBI trades at $0.00 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHBI and AAPL stock?
Key differences: Market Cap ($0.83M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (-0.3% vs 0.2%), Gross Margin (44.9% vs 47.3%).